| The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study (NCT04122235) | Sorlandet Hospital HF | 2019-11-18 |
| Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors (NCT04157985) | Dan Zandberg | 2019-11-15 |
| Comparison of 2 Types of Cervical Specimens in Patients With a Pathological Screening Smear (NCT04000477) | University Hospital, Lille | 2019-11-05 |
| HPV Testing In Polish POpulation-based Cervical Cancer Screening Program. (NCT04111835) | Maria Sklodowska-Curie National Research Institute of Oncology | 2019-10-28 |
| Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV (NCT04155294) | University of Oxford | 2019-10-28 |
| CFT Self-Help for Accessing Cervical Screening After Sexual Assault (NCT04104724) | Royal Holloway University | 2019-10-20 |
| Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA) (NCT03912415) | Biocad | 2019-10-01 |
| ElectroMagnetic-guided Interstitial Catheter Navigation for Gynecological brachyTherapy (NCT03781271) | Sunnybrook Health Sciences Centre | 2019-10-01 |
| Rucaparib Maintenance Therapy in Advanced Cervical Cancer (NCT03795272) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2019-10-01 |
| Self-sampling for Non-attenders to Cervical Cancer Screening (NCT04226313) | The Institute of Molecular and Translational Medicine, Czech Republic | 2019-09-23 |
| Sexual Health Empowerment for Women's Health (NCT03984695) | University of Kansas Medical Center | 2019-09-11 |
| VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical Cancer (NCT04017377) | Peking University Third Hospital | 2019-09-01 |
| Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer (NCT02574442) | British Columbia Cancer Agency | 2019-09-01 |
| Feasibility of Sending a Direct Send HPV Self-sampling Kit to Long-term Screening Non-attenders (NCT04909281) | Falu Hospital | 2019-08-28 |
| Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN (NCT04057924) | University Hospital, Bordeaux | 2019-08-23 |
| Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer. (NCT04061967) | Karolinska Institutet | 2019-08-19 |
| CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer (NCT04121975) | Zhejiang Cancer Hospital | 2019-08-01 |
| Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge) (NCT04000503) | University of British Columbia | 2019-08-01 |
| Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer (NCT04096911) | Buhai Wang | 2019-07-31 |
| CASUS: Improved and Quality Assured Collection of First-void Urine (NCT04480866) | Universiteit Antwerpen | 2019-07-30 |
| OCT-AF Imaging of Pre-cancers of Vulva and Cervix (NCT03285841) | British Columbia Cancer Agency | 2019-07-25 |
| A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer (NCT03970083) | Brigham and Women's Hospital | 2019-07-16 |
| e-CHEC-uP: Scaling up an Efficacious Cancer Screening Intervention for Women With Limited English (NCT03726619) | Johns Hopkins University | 2019-07-14 |
| Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers (NCT03595722) | Imperial College London | 2019-07-11 |
| Artificial Intelligence Enables Precision Diagnosis of Cervical Cytology Grades and Cervical Cancer (NCT04551287) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2019-07-01 |
| Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer (NCT04070976) | National Institute of Cancerología | 2019-07-01 |
| Cervical Carcinoma in Shatby University Hospital and Its Relation to Human Papilloma Virus (NCT05539274) | Hossam Hassan Aly Hassan El Sokkary | 2019-07-01 |
| An Analysis of the Quality of Life and Sexual Quality of Life of Cervical Cancer Radiotherapy Patients (NCT03885505) | Peking Union Medical College Hospital | 2019-06-25 |
| Comprehensive Study on the Quality of Life in Cervical Cancer Patients (NCT03967457) | Lei Li | 2019-06-19 |
| Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors (NCT04234113) | SOTIO Biotech AG | 2019-06-13 |
| Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy (NCT04106167) | Fate Therapeutics | 2019-06-11 |
| Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy (NCT03826589) | The University of Hong Kong | 2019-06-01 |
| RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer (NCT03894215) | Agenus Inc. | 2019-06-01 |
| Robot-assisted Approach to Cervical Cancer (NCT03719547) | Karolinska Institutet | 2019-05-28 |
| Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours (NCT03852823) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-05-23 |
| A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive (NCT03808857) | Genor Biopharma Co., Ltd. | 2019-05-23 |
| Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) (NCT03935204) | Xiamen University | 2019-05-13 |
| Human Papilloma Virus (HPV) Self-collection and Women Adherence (NCT05059015) | Instituto Nacional de Cancerologia, Columbia | 2019-05-01 |
| Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor (NCT03985072) | Andes Biotechnologies | 2019-04-26 |
| FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II) (NCT03853915) | University Health Network, Toronto | 2019-04-23 |
| Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 (NCT03644459) | Lynkcell Inc. | 2019-04-03 |
| Preliminary Study on the Metastatic Rate and Clinical Significance of the Anterior Leaf of Vesicouterine Ligament in Early Stage Cervical Cancer (NCT05904977) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2019-04-01 |
| Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening (NCT03873376) | Oslo University Hospital | 2019-03-11 |
| Scottish Cervical Screening and Ethnicity Project (NCT06440382) | University of Edinburgh | 2019-03-01 |
| Incidence of Unresectable Cases of Cervical Cancer (NCT05537012) | HOSSAM ALSUKARI | 2019-03-01 |
| Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study (NCT03813576) | National University Hospital, Singapore | 2019-03-01 |
| Comparing Strategies for Implementing Primary HPV Screening (NCT04371887) | Chun Chao | 2019-03-01 |
| Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer (NCT03786081) | Seagen, a wholly owned subsidiary of Pfizer | 2019-02-27 |
| INvestigational Study Into Transplantation of the Uterus (NCT04244409) | Womb Transplant UK | 2019-02-18 |
| FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors (NCT03841110) | Fate Therapeutics | 2019-02-15 |
| A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies (NCT03829501) | Kymab Limited | 2019-01-28 |
| Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors (NCT03827837) | Jiangsu HengRui Medicine Co., Ltd. | 2019-01-23 |
| Study of NEO-201 in Solid Tumors Expansion Cohorts (NCT03476681) | Precision Biologics, Inc | 2019-01-18 |
| A Phase 1 Study of [225Ac]-FPI-1434 Injection (NCT03746431) | Fusion Pharmaceuticals Inc. | 2019-01-17 |
| Impact of Cancer Treatment on the Pelvic Floor Function in Survivors of Cervical Cancer (NCT03188744) | University of Sao Paulo | 2019-01-02 |
| High Dose Rate Interstitial Brachytherapy With Three Dimensional Printing Template for Recurrent Gynecologic Tumors (NCT04127435) | Peking University Third Hospital | 2019-01-01 |
| CINtec PLUS Triage in HPV Primary Screening (NCT03721484) | Western Health and Social Care Trust | 2019-01-01 |
| Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA) (NCT03912402) | Biocad | 2018-12-25 |
| Immunogenicity and Safety Study of NBP615 in Healthy Female (NCT04453241) | SK Bioscience Co., Ltd. | 2018-12-22 |
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. (NCT03697226) | Antiva Biosciences | 2018-12-21 |
| Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer. (NCT03423082) | Nghi Nguyen | 2018-12-11 |
| QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors (NCT03228667) | ImmunityBio, Inc. | 2018-12-11 |
| Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer (NCT03994055) | National Institute of Cancerología | 2018-11-16 |
| Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. (NCT03349463) | Bital Savir-Baruch | 2018-11-14 |
| Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NCT03852979) | The Netherlands Cancer Institute | 2018-11-01 |
| Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors (NCT03755739) | Second Affiliated Hospital of Guangzhou Medical University | 2018-11-01 |
| Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826) (NCT03635567) | Merck Sharp & Dohme LLC | 2018-10-25 |
| A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer (NCT04487587) | The Clatterbridge Cancer Centre NHS Foundation Trust | 2018-10-09 |
| Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal (NCT03540069) | University of Illinois at Chicago | 2018-10-03 |
| HPV in Sentinel Lymph Nodes of Cervical Cancer Patients (NCT03749707) | University of Aarhus | 2018-10-01 |
| Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice (NCT03659110) | Beijing Chaoyang District Centre for Disease Control and Prevention | 2018-10-01 |
| An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis (NCT03876860) | Margaret Liotta | 2018-09-24 |
| A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies (NCT03652077) | Incyte Corporation | 2018-09-24 |
| Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer (NCT03367871) | University of Miami | 2018-09-06 |
| Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin (NCT03668639) | Christina Ruhlmann | 2018-09-05 |
| Acceptability and Validity of Self Sampling for High Risk HPV Detection Among Women in Maharashtra (NCT03386695) | Tata Memorial Hospital | 2018-09-01 |
| HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer (NCT03578406) | Xinqiao Hospital of Chongqing | 2018-09-01 |
| Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in Patients With Cervical Cancer (NCT03655977) | Rigshospitalet, Denmark | 2018-09-01 |
| A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Recurrent or Metastatic Cervical Cancer (NCT03676959) | Lee's Pharmaceutical Limited | 2018-08-16 |
| Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer (NCT03611517) | Leiden University Medical Center | 2018-08-07 |
| Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer (NCT04542356) | Chongqing University Cancer Hospital | 2018-08-01 |
| Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier (NCT04859530) | Prof. Patrick Petignat | 2018-08-01 |
| Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention (NCT03613493) | University of Miami | 2018-07-10 |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors (NCT03517488) | Xencor, Inc. | 2018-07-10 |
| Immunotherapy of Cervical Cancer With V3-Cervix (NCT03550755) | Immunitor LLC | 2018-07-01 |
| Promoting Cervical Cancer Screening for Emergency Department Patients (NCT03483610) | University of Rochester | 2018-06-25 |
| The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer (NCT03444376) | Genexine, Inc. | 2018-06-19 |
| A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies (NCT03538028) | Incyte Biosciences International Sàrl | 2018-06-18 |
| A Trial of Tisotumab Vedotin in Cervical Cancer (NCT03438396) | Seagen Inc. | 2018-06-12 |
| Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy. (NCT03546855) | Anhui Provincial Hospital | 2018-06-01 |
| TMTP1 Targeting Micro-metastasis LN in Laparoscopic SLN Detection in Cervical Cancer (NCT03549195) | Huazhong University of Science and Technology | 2018-06-01 |
| International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer (NCT03386734) | Centre Hospitalier Universitaire de Besancon | 2018-05-03 |
| CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers (NCT03454451) | Corvus Pharmaceuticals, Inc. | 2018-04-25 |
| 2-stage Cervical Cancer Screening in Botswana (NCT03324009) | Beth Israel Deaconess Medical Center | 2018-04-20 |
| Trial to Optimally Show the Pharmacological Action of Z-100 (NCT03476018) | Zeria Pharmaceutical | 2018-04-02 |
| Lab-on-a-chip Detection of Cervical Cancer Tumour Markers (NCT03380741) | Royal Marsden NHS Foundation Trust | 2018-04-01 |
| Colposcopic Impression in a Birth Cohort Previously Eligible for HPV-vaccination (NCT04909814) | Falu Hospital | 2018-03-14 |
| M7824 in Subjects With HPV Associated Malignancies (NCT03427411) | National Cancer Institute (NCI) | 2018-02-27 |
| Ultrasound and Photoacoustic Imaging for Cervical Cancer (NCT03318107) | Washington University School of Medicine | 2018-02-15 |
| Cervical Cancer Screening : Video Based Tutorials for ANMs/ASHAs/PHWs (NCT02783235) | Tata Memorial Hospital | 2018-01-29 |